CHICAGO, Dec 19 (Reuters) - Hospira Inc said on Wednesday it won European approval to sell Retacrit, also known as epoetin zeta, a generic version of erythropoietin, as a treatment for anemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results